@MarkScholzMD On the website PCRI, in the section about 'Azure' you cite a study from John Hopkins 'In a study of 9,300 men undergoing surgery for Azure at Johns Hopkins, 80 percent developed recurrent cancer over the subsequent 15 years.' I am trying to find out more information about it.